Groowe Groowe / Newsroom / LLY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

LLY News

Eli Lilly & Co.

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

globenewswire.com
NVDA LLY

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

globenewswire.com
NVDA LLY TMO AMGN

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study

globenewswire.com
BIIB LLY TECH

HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options

prnewswire.com
LLY

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

globenewswire.com
LLY NVO

Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients

accessnewswire.com
NVO LLY

Rejuvacare Ozempatch Ingredients Investigated: 2026 Consumer Analysis Examines Herbal Patch Formulation Disclosures

globenewswire.com
JNJ LLY

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

businesswire.com
LLY

SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39

globenewswire.com
LRCX LLY

Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery

businesswire.com
LLY